TRPV3 activation by different agonists accompanied by lipid dissociation from the vanilloid site
Science Advances · 03.05.2024 · 10 (18)
DOI: 10.1126/sciadv.adn2453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 03.05.2024. Verfasst von Kirill D Nadezhdin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA. Hauptthemen laut MEDLINE: TRPV Cation Channels, Boron Compounds. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
TRPV3 represents both temperature- and ligand-activated transient receptor potential (TRP) channel. Physiologically relevant opening of TRPV3 channels by heat has been captured structurally, while opening by agonists has only been observed in structures of mutant channels. Here, we present cryo-EM structures that illuminate opening and inactivation of wild-type human TRPV3 in response to binding of two types of agonists: either the natural cannabinoid tetrahydrocannabivarin (THCV) or synthetic agonist 2-aminoethoxydiphenylborane (2-APB). We found that THCV binds to the vanilloid site, while 2-APB binds to the S1-S4 base and ARD-TMD linker sites. Despite binding to distally located sites, both agonists induce similar pore opening and cause dissociation of a lipid that occupies the vanilloid site in their absence. Our results uncover different but converging allosteric pathways through which small-molecule agonists activate TRPV3 and provide a framework for drug design and understanding the role of lipids in ion channel function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.
ORCID-Profile: Kirill D Nadezhdin, Arthur Neuberger, Lena S Khosrof, Jeffrey Khau, Maria V Yelshanskaya, Alexander I Sobolevsky
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NIAMS NIH HHS
Zitieren
APA
Nadezhdin, K. D., Neuberger, A., Khosrof, L. S., Talyzina, I. A., Khau, J., Yelshanskaya, M. V., & Sobolevsky, A. I. (2024). TRPV3 activation by different agonists accompanied by lipid dissociation from the vanilloid site. Science Advances, 10(18). https://doi.org/10.1126/sciadv.adn2453
Vancouver
Nadezhdin KD, Neuberger A, Khosrof LS, Talyzina IA, Khau J, Yelshanskaya MV, et al. TRPV3 activation by different agonists accompanied by lipid dissociation from the vanilloid site. Science Advances. 2024;10(18). doi:10.1126/sciadv.adn2453
BibTeX
@article{Nadezhdin2024,
author = {Nadezhdin, Kirill D and Neuberger, Arthur and Khosrof, Lena S and Talyzina, Irina A and Khau, Jeffrey and Yelshanskaya, Maria V and Sobolevsky, Alexander I},
title = {TRPV3 activation by different agonists accompanied by lipid dissociation from the vanilloid site},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {18},
doi = {10.1126/sciadv.adn2453}
}
EUVIMED